Alimemazine: Difference between revisions
m (Bot: Automated text replacement (-{{SIB}} + & -{{EH}} + & -{{EJ}} + & -{{Editor Help}} + & -{{Editor Join}} +)) |
Kiran Singh (talk | contribs) No edit summary |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
{{drugbox | {{drugbox | ||
|IUPAC_name=''N'',''N'',2-trimethyl-3-phenothiazin-10-yl-propan-1-amine | |IUPAC_name=''N'',''N'',2-trimethyl-3-phenothiazin-10-yl-propan-1-amine | ||
|image=Alimemazine. | |image=Alimemazine.png | ||
|width=160px | |width=160px | ||
|CAS_number=84-96-8 | |CAS_number=84-96-8 | ||
| Line 25: | Line 25: | ||
|routes_of_administration=Oral | |routes_of_administration=Oral | ||
}} | }} | ||
__Notoc__ | |||
{{SI}} | |||
{{CMG}} | |||
==Overview== | |||
'''Alimemazine''' ([[International Nonproprietary Name|INN]]), also known as '''trimeprazine''' (former [[British Approved Name|BAN]] and [[United States Adopted Name|USAN]]; trade names '''Nedeltran''', '''Panectyl''', '''Repeltin''', '''Therafene''', '''Theralen''', '''Theralene''', '''Vallergan''', '''Vanectyl''', or '''Temaril'''), commonly provided as a [[tartrate]] salt, is a [[phenothiazine]] derivative that is used as an [[antipruritic]] (it prevents itching from causes such as [[eczema]] or [[poison ivy]], by acting as an [[antihistamine]]).<ref>{{cite web|url=http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=78032|title=PubChem CID 78032}}</ref> It also acts as a [[sedative]] and [[anti-emetic]] for prevention of [[motion sickness]]. Although it is structurally related to drugs such as [[chlorpromazine]] (Thorazine), it is not used as an anti-psychotic treatment.<ref>{{cite web|url=http://redpoll.pharmacy.ualberta.ca/drugbank/cgi-bin/getCard.cgi?CARD=APRD00258.txt|title=Drugbank:Trimeprazine}}</ref> It is no longer available in the United States.<ref>{{cite web|url=http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a601126.html|title=MedlinePlus:Trimeprazine}}</ref> | '''Alimemazine''' ([[International Nonproprietary Name|INN]]), also known as '''trimeprazine''' (former [[British Approved Name|BAN]] and [[United States Adopted Name|USAN]]; trade names '''Nedeltran''', '''Panectyl''', '''Repeltin''', '''Therafene''', '''Theralen''', '''Theralene''', '''Vallergan''', '''Vanectyl''', or '''Temaril'''), commonly provided as a [[tartrate]] salt, is a [[phenothiazine]] derivative that is used as an [[antipruritic]] (it prevents itching from causes such as [[eczema]] or [[poison ivy]], by acting as an [[antihistamine]]).<ref>{{cite web|url=http://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=78032|title=PubChem CID 78032}}</ref> It also acts as a [[sedative]] and [[anti-emetic]] for prevention of [[motion sickness]]. Although it is structurally related to drugs such as [[chlorpromazine]] (Thorazine), it is not used as an anti-psychotic treatment.<ref>{{cite web|url=http://redpoll.pharmacy.ualberta.ca/drugbank/cgi-bin/getCard.cgi?CARD=APRD00258.txt|title=Drugbank:Trimeprazine}}</ref> It is no longer available in the United States.<ref>{{cite web|url=http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a601126.html|title=MedlinePlus:Trimeprazine}}</ref> | ||
== References == | == References == | ||
{{reflist|2}} | |||
{{Antihistamines}} | {{Antihistamines}} | ||
Latest revision as of 19:18, 10 April 2015
 | |
| Clinical data | |
|---|---|
| Pregnancy category |
|
| Routes of administration | Oral |
| ATC code | |
| Pharmacokinetic data | |
| Metabolism | Hepatic |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| E number | {{#property:P628}} |
| ECHA InfoCard | {{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value). |
| Chemical and physical data | |
| Formula | C18H22N2S |
| Molar mass | 298.447 g/mol |
|
WikiDoc Resources for Alimemazine |
|
Articles |
|---|
|
Most recent articles on Alimemazine Most cited articles on Alimemazine |
|
Media |
|
Powerpoint slides on Alimemazine |
|
Evidence Based Medicine |
|
Clinical Trials |
|
Ongoing Trials on Alimemazine at Clinical Trials.gov Clinical Trials on Alimemazine at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Alimemazine
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Alimemazine Discussion groups on Alimemazine Patient Handouts on Alimemazine Directions to Hospitals Treating Alimemazine Risk calculators and risk factors for Alimemazine
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Alimemazine |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Alimemazine (INN), also known as trimeprazine (former BAN and USAN; trade names Nedeltran, Panectyl, Repeltin, Therafene, Theralen, Theralene, Vallergan, Vanectyl, or Temaril), commonly provided as a tartrate salt, is a phenothiazine derivative that is used as an antipruritic (it prevents itching from causes such as eczema or poison ivy, by acting as an antihistamine).[1] It also acts as a sedative and anti-emetic for prevention of motion sickness. Although it is structurally related to drugs such as chlorpromazine (Thorazine), it is not used as an anti-psychotic treatment.[2] It is no longer available in the United States.[3]
References
- Pages with script errors
- E number from Wikidata
- ECHA InfoCard ID from Wikidata
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drugs